Massive clonidine overdose during refill of an implanted drug delivery device for intrathecal analgesia: a review of inadvertent soft-tissue injection during implantable drug delivery device refills and its management.

OBJECTIVES The study aims to highlight the potentially serious consequences of inadvertent soft-tissue injection of intrathecal drugs such as clonidine, during refills of implanted drug delivery devices, and to suggest strategies to reduce this complication. DESIGN Case report and literature review were used. RESULTS We report the case of a 51-year-old female with chronic arm pain who sustained a massive clonidine overdose (18,000 mcg) due to inadvertent soft-tissue injection during a refill of an implanted drug delivery device, resulting in rapid loss of consciousness and significant cardiovascular instability requiring urgent resuscitation, subsequent myocardial infarction, cardiac failure, and other significant complications. The risks of inadvertent soft-tissue injection of intrathecal drugs during implanted drug delivery device refills and management of such events is poorly documented in the literature. CONCLUSION Inadvertent soft-tissue injection is possibly an underappreciated and underreported complication of intrathecal analgesia via an implanted drug delivery device. Under some circumstances, large doses of other intrathecal drugs such as bupivacaine, opioids, ziconotide, and baclofen may also be delivered by inadvertent soft-tissue injection with potentially life-threatening consequences. We recommend that practitioners, institutions, and professional bodies who manage patients with intrathecal analgesia via intrathecal drug delivery devices highlight and audit this complication and develop systems to manage it.

[1]  K. Ilett,et al.  Stability and tolerability of high concentrations of intrathecal bupivacaine and opioid mixtures in chronic noncancer pain: an open-label pilot study. , 2010, Pain medicine.

[2]  D. Turk,et al.  Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up. , 2010, Pain medicine.

[3]  C. Beecroft,et al.  Systemic toxic effects of local anaesthetics , 2010 .

[4]  C. Goodchild,et al.  CNSB004 (Leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic pain. , 2010, Pain medicine.

[5]  R. Finlayson,et al.  Treatment of complex regional pain syndrome: a review of the evidence , 2010, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[6]  R. Coffey,et al.  Mortality Associated with Implantation and Management of Intrathecal Opioid Drug Infusion Systems to Treat Noncancer Pain , 2009, Anesthesiology.

[7]  Howard S. Smith,et al.  Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain , 2009, Therapeutics and clinical risk management.

[8]  H. Shankar.  Ultrasound‐Guided Localization of Difficult‐to‐Access Refill Port of the Intrathecal Pump Reservoir , 2009, Neuromodulation : journal of the International Neuromodulation Society.

[9]  Howard S. Smith,et al.  Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. , 2009, Pain physician.

[10]  P. Staats.  Complications of Intrathecal Therapy , 2008 .

[11]  Howard S. Smith,et al.  Intrathecal drug delivery. , 2008, Pain physician.

[12]  S. Hassenbusch,et al.  Polyanalgesic Consensus Conference 2007: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel , 2007, Neuromodulation : journal of the International Neuromodulation Society.

[13]  P. Staats,et al.  The Use of Implanted Programmable Infusion Pumps in the Management of Nonmalignant, Chronic Low‐Back Pain , 2007, Neuromodulation : journal of the International Neuromodulation Society.

[14]  J. Turner,et al.  Programmable Intrathecal Opioid Delivery Systems for Chronic Noncancer Pain: A Systematic Review of Effectiveness and Complications , 2007, The Clinical journal of pain.

[15]  M. Wallace.  Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain , 2006, Expert review of neurotherapeutics.

[16]  I. Whyte,et al.  Baclofen overdose: Defining the spectrum of toxicity , 2006, Emergency medicine Australasia : EMA.

[17]  Thomas J. Smith,et al.  Massive hydromorphone dose delivered subcutaneously instead of intrathecally: guidelines for prevention and management of opioid, local anesthetic, and clonidine overdose. , 2004, Journal of pain and symptom management.

[18]  T. Deer.  A prospective analysis of intrathecal granuloma in chronic pain patients: a review of the literature and report of a surveillance study. , 2004, Pain physician.

[19]  R. Coffey,et al.  Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. , 2002, Archives of physical medicine and rehabilitation.

[20]  D. Seger.  Clonidine Toxicity Revisited , 2002, Journal of toxicology. Clinical toxicology.

[21]  B. V. van Hilten,et al.  Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. , 2000, The New England journal of medicine.

[22]  C. Frye,et al.  Hypertensive Crisis and Myocardial Infarction following Massive Clonidine Overdose , 2000, The Annals of pharmacotherapy.

[23]  C. Kappagoda,et al.  Clonidine overdose in childhood: Implications of increased prescribing , 1998, Journal of paediatrics and child health.

[24]  M. Royal,et al.  Intrathecal Opioid Conversions: the Importance of Lipophilicity , 1998, Neuromodulation : journal of the International Neuromodulation Society.

[25]  H. Kaufman,et al.  Treatment of high-dose intrathecal morphine overdose , 1994 .

[26]  J. Eisenach,et al.  Epidural Clonidine Treatment for Refractory Reflex Sympathetic Dystrophy , 1993, Anesthesiology.

[27]  F. Henretig,et al.  Clonidine poisoning in young children. , 1989, The Journal of pediatrics.

[28]  M. Lund,et al.  Failure of naloxone to reverse clonidine toxic effect. , 1983, American journal of diseases of children.

[29]  P. Yagupsky,et al.  Massive clonidine ingestion with hypertension in a 9-month-old infant. , 1983, Pediatrics.

[30]  E. Krenzelok,et al.  Naloxone administration in clonidine overdosage. , 1981, Annals of emergency medicine.

[31]  T. Deer,et al.  Rethinking algorithms of pain care: the use of the S.A.F.E. principles. , 2009, Pain medicine.

[32]  J. Senard,et al.  Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. , 2007, Current topics in medicinal chemistry.

[33]  H. Adriaensen,et al.  Accidental overdosing with intraspinal morphine caused by misprogrammation of a Synchromed pump: a report of two cases. , 1997, Acta anaesthesiologica Belgica.

[34]  P. Lumb,et al.  Successful treatment of a massive intrathecal morphine overdose. , 1995, Anesthesiology.

[35]  S. Domino,et al.  Relationship between plasma concentrations of clonidine and mean arterial pressure during an accidental clonidine overdose. , 1986, British journal of clinical pharmacology.